{'fraction_non_alphanumeric': 0.03485107421875, 'fraction_numerical': 0.02069091796875, 'mean_word_length': 4.793847241867044, 'pattern_counts': {'":': 0, '<': 7, '<?xml version=': 0, '>': 1, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
How much total ovarian tissue can be removed without compromising ovarian function? An animal study

Purpose Until now, it is not clear how much total ovarian tissue can be removed without affecting ovarian functions. Aim to investigate impact of stepwise removed ovarian tissue on endocrine hormone levels reflecting ovarian function, follicle morphology and weight in rats. Methods The study was performed with six groups of animals, each consisting of six ten-week-old Sprague-Dawley rats. A blood test was performed on the day of surgery (baseline) and fortnightly thereafter to assess serum hormones reflecting ovarian function: estradiol (E2), progesterone (P), follicle-stimulating hormone (FSH), anti-Müllerian hormone (AMH), inhibin B (INHB); weight was also assessed. The ovaries obtained from surgical resection and from the rats sacrificed 12 weeks after surgery were stained with hematoxylin-eosin. Surgeries in the groups; [%] of remaining total ovarian tissue: Group 1, non-ovariectomized [100% tissue]. Group 2, half of left ovary excised [75% tissue]. Group 3, left ovary excised [50% tissue]. Group 4, left ovary + half of right ovary excised [25% tissue]. Group 5, left ovary + three quarters of right ovary excised [12.5% tissue]. Group 6, bilateral ovariectomy [0% tissue]. Results During the 12 weeks, group 4, 5 and 6 had higher FSH and lower AMH and INHB values compared to the control (group 1) ( p <0.05), but in group 4 production of E2 and P was not significantly different from control ( p >0.05). All ovarian function parameters completely stopped in group 5, i.e. the same as the bilateral ovariectomized rats (group 6). Weight significantly increased in group 6 ( p <0.05). Follicle morphology at baseline and 12 weeks after surgery in groups 2-5 was not significantly different to the control. Conclusions Our animal study confirms that removal of one ovary maintains the remaining ovarian tissue's potency for normal hormone production, as


Introduction
Ovaries play a fundamental role in fertility and steroidogenesis [1]. Removal of ovarian tissue may be necessary for pathological reasons, e.g. in patients with ovarian endometriosis and especially for ovarian tissue cryopreservation (OTC), an option for fertility protection in patients with certain cancers or in general to preserve ovarian function by ovarian tissue retransplantation (OTCT). Hormone replacement therapy (HRT) is recommended to avoid consequences of estradiol deficiency like climacteric symptoms and osteoporosis. However, many women are reluctant to take HRT due to the associated health risks, such as breast cancer, venous thrombosis, myocardial infarction and stroke [2]. Furthermore, HRT is contraindicated in some women, e.g. in patients with breast cancer who now often undergo OTC/OTCT for fertility protection. Indeed, OTCT may be not successful or may no longer be possible because of deterioration of the primary cancer and/or development of metastases, and these patients will develop POI with all its negative consequences. The prevalence of POI is as high as 7% in UK, which may be higher than 10% in China, of which 20-56% are caused by iatrogenic factors, and radiotherapy and/or chemotherapy can cause POI in 70-100% of women [3][4][5][6]. POI not only reduces women's fertility, but also causes various menopausal symptoms, osteoporosis, cardiovascular disease etc. Therefore, the question of how much total ovarian tissue, i.e. excisions in both ovaries, can be removed without stopping/finishing/compromising ovarian function, is of great practical interest.
Fertility potential is related to the total number and quality of primordial follicles remaining in the ovaries, the ovarian reserve [7], which can be estimated by serum levels of anti-Müllerian hormone (AMH) and inhibin B (INHB) [8,9]. OTC/OTCT is an emerging fertility and endocrine function preservation method, performed to avoid or treat POI [10,11]. Ovarian tissue is frozen before radio-/chemotherapy etc., and later retransplanted [12]. OTC/OTCT is recommended especially if gonadotoxic treatment cannot be delayed and is the exclusive method of preserving fertility in prepubertal girls [11,13]. It is now a widely performed procedure, especially in Europe, as seen in the "FertiPROTEKT network" [14,15]. More than 160 children have been born with this technology worldwide [16,17].
The "International Fertility Protection Center -Ovarian Tissue Cryobank of the Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing, China" is currently the first and only one in China, established with the help of international experts [18]. We have already cryopreserved more than 300 tissues within a short time and have published the first case of OTCT in China [19] and the Chinese guidelines for OTC/OTCT [20].
Within our research we have tried to optimize the protocol for OTC/OTCT [12] and gain new insights for further improvement, like this also is the aim of the present study. Up to now it was not clear how much ovarian tissue can be removed without compromising ovarian function. A systematic review [21] on OTC/OTCT summarized that unilateral oophorectomy was chosen in 11% of cases, partial decortication (removal of 1/3 to 1/2 of one ovary) in 79% and multiple biopsies in 8% of cases. Donnez et al. [17] and our Chinese guidelines [20] indicated that at least half of unilateral ovarian tissue should be cryopreserved; however, for severe cases (especially after cancer), removal of even more tissue may be necessary. In the European "FertiPROTEKT network", half an ovary was removed in 97% [22]. Removal of one entire ovary is currently recommended for prepubertal girls due to the small size of the ovaries [23].
Obtaining multiple biopsy samples from one ovary has not been shown to compromise future hormone production [17]. However, we did not find any data about ovarian function if more ovarian tissue is removed. Thus, the objective of our study was to assess how much tissue can be removed without stopping ovarian function.

Changes in Weight
Body weight of the six groups at baseline (day of surgery) and fortnightly during the 12 weeks' study is shown in Table 1. Significant increases in weight in group 6 compared with group 1 were found (p < 0.05), there were no significant changes in all other groups. The weight in the bilateral oophorectomy group (group 6) was higher than in control from week 2 to 12 after surgery. Data are expressed as mean ± SD *P<0.05 compared with the control group (group 1) Assessment of FSH, E2 and P Serum E2, P and FSH values of the rats in the 6 groups are shown in Table 2 and Fig. 2.
Group 5 and 6 had lower E2 and P values than group 1. However, the levels for groups 2, 3, and 4 were not significantly different to group 1 (p 0.05). Remarkably, despite removal of 75% of total ovarian tissue (group 4), the production of E2 and P still was normal. There was a significant increase in FSH values in group 4, 5 and 6 compared to group 1, but no significant difference to the control in group 2 and 3 (p 0.05). and P values in groups 5 and 6 were lower than the control from week 2 to 12 after surgery. FSH values in groups 4, 5 and 6 were higher than the control from week 2 to 12 after surgery.
Assessment of AMH and INHB group 4, 5 and 6 had significantly lower AMH values than group 1 (p < 0.05), whereas the levels in group 2 and 3 were not statistically different from group 1 (p 0.05). At 2 and 4 weeks, group 5 and 6, and from 6 to 12 weeks also group 4 had lower INHB values than group 1 (p<0.05). The levels in group 2 and 3 were not statistically different from group 1 (p 0.05).

Ovarian volume and morphology
The histological images of the ovaries stained by HE are shown in Fig. 4. All ovaries in the different groups showed normal follicle morphology (scale bar = 100 µm). Regarding ovarian volume, we did not find a significant difference between group 3 and control (there was also no significant difference in FSH and LH production), meaning no compensatory increase of the remaining ovary occurred.

Discussion
Main results and possible practical consequences In the present study, ovarian function of rats was investigated with a stepwise reduction of the total ovarian tissue from 0% (group 1) to 25%, 50%, 75%, 82.5% and 100% in groups 2,3,4,5,6, respectively. The most remarkable result is that excision of up to 75% of total ovarian tissue will still allow normal production of E2 and P. To our knowledge, has been shown for the first time in an animal model.
If this is also would be true for women undergoing removal of ovarian tissue for pathological reasons, e.g. ovarian endometriosis, in patients with cancer or to remove enough tissue for cryopreservation, the consequence would be that despite only 25% tissue remaining, HRT for treatment of estrogen-deficiency consequences such as climacteric complaints or osteoporosis would not be necessary. Possible detrimental HRT risks like breast cancer, thromboembolism and stroke could therefore be avoided [2]. This is important when using OTC/OTCT for fertility protection, also for women not wanting fertility but with POI for other reasons [15 − 18,20].
Hormone levels for assessment of ovarian function We found in our study that removal of < 75% of the total ovarian tissue (group 2,3,4) maintains normal production of E2 and P (i.e. no significant difference to control), whereas FSH was significantly increased after 75% tissue excision (i.e. in group 4,5 and 6). It is well known that despite the negative feedback mechanisms within the HPO axis, E2 and P values can remain normal but FSH can increase, even in cases of higher E2 levels, especially during menopausal transition and often together with a decrease in INHB [24 − 26] .
From the AMH levels it can be suggested that in all experimental groups (2 to 6) there was a decrease in ovarian reserve directly after surgery. It has been suggested that serum AMH levels show the greatest sensitivity to ovarian insufficiency, particularly a strong correlation with the number of early antral follicles. This can explain the early decrease in AMH after excision of only 25% of total ovarian tissue. The decrease in INHB was later (starting 6 weeks after surgery) compared to AMH (starting 2 weeks after surgery) and was only seen if 75% and more of the total ovarian tissue was removed, i.e. in group 4,5 and 6. Considering these results with INHB, the decrease is larger with the time after surgery and, as expected, with the amount of tissue removal.
We can conclude that ovarian reserve is starting to be significantly decreased after 75% removal, i.e. in group 4,5 and 6. However, E2 and P are still produced in group 4 with normal values. This hormonal constellation can be clinically compared with women during hormonal transition where even pregnancy is possible with occasional ovulation and young women with a similar hormonal constellation (for example POI) can also become pregnant [27].
If fertility could be maintained after up to 75% excision of total ovarian tissue (which needs further research), our animal data strongly suggest that HRT can be avoided if also shown in human studies. In context with very new data investigating breast cancer risk during HRT use, which is mostly feared by patients and doctors, this result could be important. According to a recent meta-analysis including 58 studies [28], the number of additional breast cancer patients when using HRT is about five fold higher than calculated from earlier studies, with the striking result that even only one year of treatment with HRT can significantly increase breast cancer risk. This is especially important for OTC/OTCT, because for most patients retransplantation is only possible one or two even more years after cryopreservation.

Ovaries' volume and morphology
There was no significant difference in ovarian volume between group 3 and control.
However, this may be due to the short observation time. This assessment was of interest because a compensatory increase in volume of the remaining ovary is known for women after unilateral oophorectomy [29].
No morphological differences in the follicles were seen in group 2-5 12 weeks after surgery compared with the control (Fig. 4) primordial follicles may be generated from germline stem cells and oocytes develop from primitive germline cells harvested from women of reproductive age [33]. Normal values of FSH and INHB, as seen in group 3, may also be explained by greater feedback sensitivity in the HPO-axis of the remaining ovary.
Some studies suggest that unilateral oophorectomy is effective in restoring long term ovulation function in PCOS patients and after treatment of cancer [34,35]. It is reassuring that women with only one ovary do not seem to have a reduced potential to conceive, either naturally or via IVF [35]. However, the outcomes of unilateral oophorectomy may differ in these populations and removing one ovary can be a strong risk factor for early menopause [32], particularly before the age of 35 years. It can adversely affect the fertility potential of women who already have reduced ovarian reserve and multiple risk factors for early menopause [34]. Despite our encouraging experimental results, further research is needed for these patients, and unilateral oophorectomy should not be currently recommended.

Changes in Weight
Among the five experimental groups, only the bilateral oophorectomy group (group 6) showed significant changes in weight -a significant gain compared to control (Table 1). This is consistent with clinical findings in women with weight increase after menopause [36]. This may be due to decreased estrogen production causing changes in metabolic function (deterioration in lipid and glucose metabolism) with changes in the energy budget. In our study, all rats in group 6 were acutely postmenopausal because of "surgical menopause". Increased weight was also observed in group 5, but was not significant. We speculate that this was not because of 17.5% ovarian tissue remaining, but because they were postmenopausal since E2 and P significantly decreased and FSH increased, comparable to group 6.
This study is the first to determine the effects of stepwise removal of ovarian tissue on endocrine and reserve function in rats. It may have been possible to obtain more information with more groups, e.g. testing 32.5% ovarian tissue. However, after discussion with our ethical committee, we wanted to limit the number of animals used, and we doubt that more relevant information would have been obtained by testing more groups. And we designed 6 rats in each group according to the suggestions from the experts of ethical committee. We investigated the early stage impact of stepwise removed ovarian tissue, so we only observed 12 weeks after surgery. Further long-term observation of ovarian function could be of interest, especially for group 4, where we could expect that not only the production of E2 and P is maintained despite of 75% removal of total ovarian tissue, but other parameters could recover, also leading to maintenance of fertility.

Summary and Conclusion
Excision of ovarian tissue is necessary for women wanting cryopreservation and later retransplantation to preserve fertility and for pathological changes in the ovaries.
Function of the remaining tissue is wanted because retransplantation of tissue may not be successful. HRT to treat and prevent estrogen deficiency sequelae is often rejected because of potential risks or may not be possible due to contraindications.
Our animal study confirms that removal of one ovary does not affect the secretion of E2, P, FSH, AMH and INHB, i.e. the function of ovarian tissue is maintained. However, to our knowledge we have demonstrated for the first time that even removal of up to 75% of the total ovarian tissue can still maintain normal production of E2 and P. If confirmed in women, risky HRT could be avoided. It may be appropriate in the future to increase the excision volume of ovarian tissue for cryoconservation to achieve enough ovarian potency after retransplantation, since chemotherapy can lead to severe POI. Further research is needed to investigate if not only E2/P production, but also fertility can be maintained with only 25% remaining total ovarian tissue.

Animals and Grouping
Healthy